Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ)
CNY 5.88
(3.34%)
CNY 5.88
(3.34%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.57 Billion CNY | 7.52% |
| 2022 | 4.25 Billion CNY | 26.92% |
| 2021 | 3.35 Billion CNY | 16.63% |
| 2020 | 2.87 Billion CNY | 1.22% |
| 2019 | 2.84 Billion CNY | 3.46% |
| 2018 | 2.74 Billion CNY | 2.53% |
| 2017 | 2.67 Billion CNY | 6.01% |
| 2016 | 2.52 Billion CNY | 4.17% |
| 2015 | 2.42 Billion CNY | 14.61% |
| 2014 | 2.11 Billion CNY | 19.57% |
| 2013 | 1.77 Billion CNY | 13.43% |
| 2012 | 1.56 Billion CNY | 7.48% |
| 2011 | 1.45 Billion CNY | 5.98% |
| 2010 | 1.37 Billion CNY | 1.86% |
| 2009 | 1.34 Billion CNY | 485.27% |
| 2008 | 229.87 Million CNY | 42.24% |
| 2007 | 161.6 Million CNY | 48.22% |
| 2006 | 109.03 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 4.28 Billion CNY | -6.39% |
| 2024 Q3 | 4.32 Billion CNY | 8.99% |
| 2024 Q2 | 3.97 Billion CNY | -7.37% |
| 2023 FY | 4.57 Billion CNY | 7.52% |
| 2023 Q1 | 4.75 Billion CNY | 11.7% |
| 2023 Q4 | 4.57 Billion CNY | 4.02% |
| 2023 Q3 | 4.4 Billion CNY | -2.81% |
| 2023 Q2 | 4.52 Billion CNY | -4.78% |
| 2022 Q2 | 4.95 Billion CNY | 36.89% |
| 2022 Q3 | 4.15 Billion CNY | -16.17% |
| 2022 Q4 | 4.25 Billion CNY | 2.46% |
| 2022 Q1 | 3.62 Billion CNY | 7.94% |
| 2022 FY | 4.25 Billion CNY | 26.92% |
| 2021 FY | 3.35 Billion CNY | 16.63% |
| 2021 Q2 | 2.9 Billion CNY | -0.7% |
| 2021 Q3 | 3.28 Billion CNY | 12.98% |
| 2021 Q4 | 3.35 Billion CNY | 2.15% |
| 2021 Q1 | 2.92 Billion CNY | 1.77% |
| 2020 Q3 | 2.86 Billion CNY | 1.57% |
| 2020 Q1 | 2.94 Billion CNY | 3.54% |
| 2020 Q4 | 2.87 Billion CNY | 0.42% |
| 2020 FY | 2.87 Billion CNY | 1.22% |
| 2020 Q2 | 2.82 Billion CNY | -4.15% |
| 2019 FY | 2.84 Billion CNY | 3.46% |
| 2019 Q1 | 2.88 Billion CNY | 5.16% |
| 2019 Q4 | 2.84 Billion CNY | 2.5% |
| 2019 Q3 | 2.77 Billion CNY | -1.27% |
| 2019 Q2 | 2.8 Billion CNY | -2.77% |
| 2018 Q2 | 2.76 Billion CNY | -2.84% |
| 2018 Q3 | 2.78 Billion CNY | 0.65% |
| 2018 FY | 2.74 Billion CNY | 2.53% |
| 2018 Q4 | 2.74 Billion CNY | -1.44% |
| 2018 Q1 | 2.85 Billion CNY | 6.38% |
| 2017 Q4 | 2.67 Billion CNY | -0.54% |
| 2017 FY | 2.67 Billion CNY | 6.01% |
| 2017 Q3 | 2.69 Billion CNY | -1.55% |
| 2017 Q2 | 2.73 Billion CNY | 3.08% |
| 2017 Q1 | 2.65 Billion CNY | 5.02% |
| 2016 FY | 2.52 Billion CNY | 4.17% |
| 2016 Q3 | 2.56 Billion CNY | 1.83% |
| 2016 Q2 | 2.51 Billion CNY | -0.72% |
| 2016 Q1 | 2.53 Billion CNY | 4.48% |
| 2016 Q4 | 2.52 Billion CNY | -1.38% |
| 2015 FY | 2.42 Billion CNY | 14.61% |
| 2015 Q1 | 2.3 Billion CNY | 8.81% |
| 2015 Q4 | 2.42 Billion CNY | -1.59% |
| 2015 Q3 | 2.46 Billion CNY | -0.75% |
| 2015 Q2 | 2.48 Billion CNY | 7.84% |
| 2014 Q3 | 1.97 Billion CNY | 6.32% |
| 2014 Q2 | 1.86 Billion CNY | -1.03% |
| 2014 FY | 2.11 Billion CNY | 19.57% |
| 2014 Q1 | 1.87 Billion CNY | 6.15% |
| 2014 Q4 | 2.11 Billion CNY | 7.05% |
| 2013 Q2 | 1.66 Billion CNY | -1.53% |
| 2013 Q4 | 1.77 Billion CNY | 0.93% |
| 2013 FY | 1.77 Billion CNY | 13.43% |
| 2013 Q1 | 1.69 Billion CNY | 8.32% |
| 2013 Q3 | 1.75 Billion CNY | 5.37% |
| 2012 Q3 | 1.54 Billion CNY | 8.05% |
| 2012 Q2 | 1.43 Billion CNY | -7.85% |
| 2012 Q4 | 1.56 Billion CNY | 0.74% |
| 2012 FY | 1.56 Billion CNY | 7.48% |
| 2012 Q1 | 1.55 Billion CNY | 7.16% |
| 2011 FY | 1.45 Billion CNY | 5.98% |
| 2011 Q4 | 1.45 Billion CNY | 2.13% |
| 2011 Q3 | 1.42 Billion CNY | 3.37% |
| 2011 Q1 | 1.39 Billion CNY | 2.01% |
| 2011 Q2 | 1.37 Billion CNY | -1.58% |
| 2010 Q4 | 1.37 Billion CNY | 2.75% |
| 2010 Q1 | 1.22 Billion CNY | -8.82% |
| 2010 Q2 | 1.24 Billion CNY | 1.08% |
| 2010 Q3 | 1.33 Billion CNY | 7.55% |
| 2010 FY | 1.37 Billion CNY | 1.86% |
| 2009 FY | 1.34 Billion CNY | 485.27% |
| 2009 Q4 | 1.34 Billion CNY | 285.03% |
| 2009 Q3 | 349.42 Million CNY | 29.4% |
| 2009 Q2 | 270.04 Million CNY | 0.0% |
| 2008 FY | 229.87 Million CNY | 42.24% |
| 2008 Q4 | 229.87 Million CNY | 0.0% |
| 2007 FY | 161.6 Million CNY | 48.22% |
| 2006 FY | 109.03 Million CNY | 0.0% |